ArticleFrontiers in aging2026
Case Report: Exceptional longevity in turner syndrome.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Turner Syndrome (TS), caused by complete or partial monosomy of chromosome X, is associated with increased morbidity and reduced life expectancy, largely driven by cardiovascular, endocrine, and metabolic complications. Here, we report the case of a 75-year-old woman with a confirmed diagnosis of non-mosaic TS (45,X) who remains clinically stable and functionally independent, beyond the expected survival for this condition. Notably, her mother is currently 101 years old, indicating a familial background of exceptional longevity. To explore the potential contribution of inherited genetic factors to this favorable phenotype, whole-genome sequencing (WGS) was performed in both the TS patient and her centenarian mother aiming to identify variants potentially associated with healthy aging and longevity. Hematological and biochemical analyses were subsequently used to functionally support the genetic and clinical findings, revealing preserved metabolic, inflammatory, and hematological profiles for the patient age. Together, these data suggest that a favorable genetic background may partially counterbalance the risks traditionally associated with X chromosome monosomy, contributing to preserved functional status into older age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.